MedTrace Logo

LIFEGUARD Study - Continuous Respiratory Monitoring on the General Ward

NCT03571646 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2021-03-08

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to document how often and how severe are the breathing difficulties that patients suffer, while recovering on a general ward following a serious operation

Conditions

  • Respiratory Complication

Interventions

BEHAVIORAL

Capnostream 20 monitoring

Continuous monitoring on a general ward

DEVICE

PM1000N-RR monitoring

Continuous monitoring on a general ward

Sponsors & Collaborators

  • Medtronic - MITG

    lead INDUSTRY

Principal Investigators

  • Andreas Hoeft, MDPhD · Universitätsklinikum Bonn (AöR), D-53127 Bonn - Germany

  • Michael Sander, Dr.Med · Universitätsklinikum Gießen und Marburg (UKGM) , 20043 Marburg - Germany

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-09
Primary Completion
2019-12-14
Completion
2019-12-14
FDA Device
Yes

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03571646 on ClinicalTrials.gov